Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?
November 25, 2015|
A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.